<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Secondary <z:hpo ids='HP_0011009'>acute</z:hpo> lymphocytic <z:hpo ids='HP_0001909'>leukemias</z:hpo> (ALL) are uncommon events in the pediatric patient population </plain></SENT>
<SENT sid="1" pm="."><plain>There are few detailed reports on the laboratory characteristics and clinical course of patients with secondary lymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Historically, these patients have had a poor outcome </plain></SENT>
<SENT sid="3" pm="."><plain>We report two patients treated at one institution who developed treatment-related secondary ALL </plain></SENT>
<SENT sid="4" pm="."><plain>Both patients underwent hematopoietic stem cell transplantation, one with a compatible unrelated donor cord blood unit and one with an HLA-matched sibling donor bone marrow </plain></SENT>
<SENT sid="5" pm="."><plain>One of the two patients survives disease-free 3 years after transplantation </plain></SENT>
</text></document>